Compare Novartis AG (NVS) vs Progressive Corp (PGR) Price & Performance

Novartis AGTrade

Progressive CorpTrade

Price performance (Past 24H)

Key statistics

Novartis AG vs Progressive Corp — how do they compare? Novartis AG trades at $153.88 (market cap $290.25B), while Progressive Corp trades at $207.39 (market cap $123.39B). The key difference: Novartis AG is far larger — about 2.4× Progressive Corp's market cap, and Progressive Corp pays the higher dividend (6.55%). Which is the better fit depends on your goals.

	NVS	PGR
Market Cap	$290.25B	$123.39B
Sector	Health	Financials
52-Week High	$168.62	$252.68
52-Week Low	$113.50	$190.40
Enterprise Value	$330.27B	$131.61B
Dividend Yield	3.17%	6.55%

View details →View details →

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

NVS

Novartis Q2 earnings expected at $2.17 EPS, $14.07B revenue amid patent loss impact and key drug trials ahead.Gordon Thompson · 23 hours agoNeutral New report details 1,230+ bioinformatics deals, revealing market trends and deal structures through 2026Researchandmarkets.Com · 4 days agoNeutral FDA approves Fabhalta as first drug to significantly slow kidney decline in IgAN patientsNovartis · 4 days agoBullish View details →

PGR

Winnebago and Progressive partner to enhance RV ownership with integrated insurance solutions.GlobeNewsWire · 5 hours agoBullish View details →

About Novartis AG

Novartis develops and manufactures healthcare products through two segments: Innovative Medicines and Sandoz. It generates the vast majority of its revenue from Innovative Medicines segment consisting global business franchises in oncology, ophthalmology, neuroscience, immunology, respiratory, cardio-metabolic, and established medicines. The company sells its products globally, with the United States representing close to one third of total revenue.